We are live on
!
Find out more
ACM
Atika Capital Management Portfolio holdings
AUM
$796M
1-Year Est. Return
167.57%
This Fund
S&P 500
This Quarter
Est. Return
+24.25%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$518M
AUM Growth
+$42.9M
(+9%)
Cap. Flow
-$57M
Cap. Flow
% of AUM
-11.01%
Top 10 Holdings %
Top 10 Hldgs %
30.31%
Holding
98
New
21
Increased
21
Reduced
22
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$11.4M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$10.8M |
| 3 |
Thor Industries
THO
|
+$8.71M |
| 4 |
Centene
CNC
|
+$7.27M |
| 5 |
Sarepta Therapeutics
SRPT
|
+$7.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$8.32M |
| 2 |
MDCO
Medicines Co
MDCO
|
+$8.27M |
| 3 |
Walt Disney
DIS
|
+$6.25M |
| 4 |
Q2 Holdings
QTWO
|
+$5.91M |
| 5 |
Roku
ROKU
|
+$5.36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.56% |
| 2 | Technology | 16.92% |
| 3 | Consumer Discretionary | 12.84% |
| 4 | Communication Services | 10.59% |
| 5 | Financials | 4.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Okta
OKTA
$24.6B
| $7.85M | 1.51% |
68,000
-32,000
| -32% | -$3.68M |
|
27
Tandem Diabetes Care
TNDM
$1.38B
| $7.81M | 1.51% |
131,000
-11,000
| -8% | -$678K |
|
|
AZUL
28
DELISTED
Azul
AZUL
| $7.7M | 1.49% |
180,000
+35,000
| +24% | +$1.35M |
|
29
MongoDB
MDB
$28.8B
| $7.5M | 1.45% |
57,000
+7,000
| +14% | +$919K |
|
30
CALL
Vertex Pharmaceuticals
VRTX
$119B
| – | – |
0
| – | – |
|
|
ARNA
31
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $7.36M | 1.42% |
162,000
-19,000
| -10% | -$898K |
|
32
Ascendis Pharma A/S
ASND
$16B
| $7.23M | 1.4% |
52,000
+27,000
| +108% | +$3M |
|
33
argenx
ARGX
$52B
| $7.19M | 1.39% |
44,800
| – | – |
|
34
Vulcan Materials
VMC
$36.7B
| $7.08M | 1.37% |
49,200
-11,800
| -19% | -$1.69M |
|
|
EXAS
35
DELISTED
Exact Sciences
EXAS
| $6.71M | 1.29% |
72,500
-27,500
| -28% | -$2.42M |
|
36
Ollie's Bargain Outlet
OLLI
$4.51B
| $6.53M | 1.26% |
+100,000
| New | +$6.33M |
|
37
Lyft
LYFT
$6.22B
| $6.45M | 1.25% |
+150,000
| New | +$6.58M |
|
38
EPAM Systems
EPAM
$5.6B
| $6.37M | 1.23% |
30,000
| – | – |
|
39
HEICO Corp Class A
HEI.A
$36.6B
| $6.36M | 1.23% |
71,000
+9,000
| +15% | +$857K |
|
|
CTLT
40
DELISTED
CATALENT, INC.
CTLT
| $6.31M | 1.22% |
112,100
| – | – |
|
41
KB Home
KBH
$3.45B
| $6.17M | 1.19% |
+180,000
| New | +$6.22M |
|
42
Elevance Health
ELV
$83B
| $6.04M | 1.17% |
+20,000
| New | +$5.5M |
|
43
T-Mobile US
TMUS
$190B
| $5.8M | 1.12% |
74,000
+37,000
| +100% | +$2.91M |
|
44
Lowe's Companies
LOW
$119B
| $5.75M | 1.11% |
48,000
+18,000
| +60% | +$2.06M |
|
|
SGI
45
Somnigroup International
SGI
$14B
| $5.66M | 1.09% |
+260,000
| New | +$5.44M |
|
|
GRA
46
DELISTED
W.R. Grace & Co.
GRA
| $5.59M | 1.08% |
80,000
-53,000
| -40% | -$3.56M |
|
|
KRTX
47
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $5.5M | 1.06% |
+73,000
| New | +$3.2M |
|
48
Shake Shack
SHAK
$2.61B
| $5.18M | 1% |
87,000
-16,000
| -16% | -$1.15M |
|
49
UnitedHealth
UNH
$377B
| $5.14M | 0.99% |
+17,500
| New | +$4.58M |
|
50
Century Communities
CCS
$1.96B
| $4.95M | 0.96% |
+181,000
| New | +$5.3M |
|
Similar funds
AGA
RIM
ACM
CAM
LSA
GWA
HP
Atika Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Atika Capital Management held 98 positions worth $518M, up 9% from $475M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Atika Capital Management withdrew a net $57M in Q4 2019, closing 25 positions and reducing 22 holdings. Its most notable exit was Twitter, Inc., an estimated $8.32M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Atika Capital Management opened a new position in Reata Pharmaceuticals, Inc. Class A Common Stock worth $12.8M.
- Atika Capital Management's largest Q4 2019 buy was Reata Pharmaceuticals, Inc. Class A Common Stock: 62,500 shares worth $12.8M.
- Atika Capital Management added most to Enphase Energy in Q4 2019, an estimated $3.43M increase.
- Atika Capital Management's biggest Q4 2019 reduction was Roku, cutting an estimated $5.36M.
- Atika Capital Management fully exited Twitter, Inc. in Q4 2019, selling an estimated $8.32M.
- Atika Capital Management's ten largest holdings make up 30% of its $518M portfolio in Q4 2019.
- Atika Capital Management opened 21 new positions and closed 25 in Q4 2019.
- Atika Capital Management's portfolio value rose 9% quarter-over-quarter to $518M.
Based on Atika Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.